SDC for Lung Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or Chemoradiation

Standardized Data Collection (SDC) for Lung Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or Chemoradiation (SDC Lung).

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01855191

Acronym

SDC lung

Enrollment

864

Registered

2013-05-16

Start date

2013-06-30

Completion date

2019-02-28

Last updated

2019-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Brief summary

Introducing standardized data collection (SDC) for lung cancer patients to improve the performance of the prediction models.

Detailed description

All patients planned for curative primary or postoperative radiotherapy can be included. Patients will be treated according to the institutional protocol. It is optional to collect a saliva sample for genetic profiling. Follow up at five time points: * 2 weeks after RT * 3 months after RT * 6 months after RT * 12 months after RT * 24 months after RT At these time points, toxicity will be assessed. In addition, patients will receive a short questionnaire by mail at eight time points.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* All patients planned for curatively intended radiotherapy or postoperative radiotherapy * Recurrent disease

Exclusion criteria

* All patients planned for palliative radiotherapy

Design outcomes

Primary

Measure	Time frame
Two-year survival rate	24 months after RT

Secondary

Measure	Time frame	Description
Change in dyspnea	during 24 months after RT	—
Change in cough	During 24 months after RT	—
Change in dysphagia	During 24 months after RT	—
Patient-rated generic quality of life	During 24 months after RT	Measured by Euroqol questionnaire

Countries

Netherlands

Outcome results